Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor-mutant non-small cell lung cancer: A prospective, multicenter, dose-modification study.
Yukari TsubataTakeshi MasudaKosuke HamaiMasaya TaniwakiAkari TaninoTakamasa HottaMegumi HamaguchiShunichi HamaguchiMasahiro YamasakiNobuhisa IshikawaKazunori FujitakaAkihisa SutaniTakeshi IsobePublished in: Geriatrics & gerontology international (2021)
Many older patients with epidermal growth factor receptor-mutant non-small cell lung cancer might require treatment dose reduction. Further studies are required to develop individualized treatments for older patients with lung cancer. Geriatr Gerontol Int 2021; 21: 881-886.